October 24, 2016: At the beginning of this year, Shire acquired Baxalta. Only six months earlier, in July 2015, Baxalta spun off from Baxter International.
October 24, 2016: With biotech stocks in the doldrums, investors are anxious that the results of the presidential election in two weeks will make matters worse. Bret Jensen, writing for Seeking Alpha, looks at two small cap biotech companies that appear to be rallying.
October 24, 2016: The FDA placed a partial hold on Aduro Biotech’s LADD trials. Aduro’s LADD technology is a method of engineering the bacteria Lysteria monocytogenes into therapeutics that stimulate targeted immune response to specific tumor antigens.
October 24, 2016: After 14 months of waiting, J&J opened its new $23.5M North American Global Services Center headquarters in Tampa—a facility that is expected to bring 500 new jobs to the coastal city.